Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Evidence-based development of liver allocation: a review.

Merion RM, Sharma P, Mathur AK, Schaubel DE.

Transpl Int. 2011 Oct;24(10):965-72. doi: 10.1111/j.1432-2277.2011.01274.x. Epub 2011 May 25. Review.

2.

Development of the allocation system for deceased donor liver transplantation.

Coombes JM, Trotter JF.

Clin Med Res. 2005 May;3(2):87-92. Review.

3.

Liver allocation and distribution: possible next steps.

Washburn K, Pomfret E, Roberts J.

Liver Transpl. 2011 Sep;17(9):1005-12. doi: 10.1002/lt.22349.

4.

Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.

Cejas NG, Villamil FG, Lendoire JC, Tagliafichi V, Lopez A, Krogh DH, Soratti CA, Bisigniano L.

Liver Transpl. 2013 Jul;19(7):711-20. doi: 10.1002/lt.23665.

5.

A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.

Vitale A, Volk ML, De Feo TM, Burra P, Frigo AC, Ramirez Morales R, De Carlis L, Belli L, Colledan M, Fagiuoli S, Rossi G, Andorno E, Baccarani U, Regalia E, Vivarelli M, Donataccio M, Cillo U; Liver Transplantation North Italy Transplant program (NITp) working group.

J Hepatol. 2014 Feb;60(2):290-7. doi: 10.1016/j.jhep.2013.10.010. Epub 2013 Oct 23. Erratum in: J Hepatol. 2014 Jun;60(6):1336. Multiple investigator names added.

PMID:
24161408
6.

Competition in liver transplantation: helpful or harmful?

Saidi RF, Razavi M, Cosimi AB, Ko DS.

Liver Transpl. 2015 Feb;21(2):145-50. doi: 10.1002/lt.24039.

7.

Evolving trends in liver transplantation: listing and liver donor allocation.

Wiesner RH.

Clin Liver Dis. 2014 Aug;18(3):519-27. doi: 10.1016/j.cld.2014.05.014. Review.

PMID:
25017073
8.

Impact of Model for End-Stage Liver Disease in the occurrence of infectious events and survival in a cohort of liver transplant recipients.

Clemente WT, Romanelli RM, Faria LC, Lima SS, Jesus LA, Cortes JR, Sanches MD, Cançado OL, Lima AS.

Transplant Proc. 2013 Jan-Feb;45(1):297-300. doi: 10.1016/j.transproceed.2012.02.046.

PMID:
23375318
9.

Advances in liver transplantation allocation systems.

Schilsky ML, Moini M.

World J Gastroenterol. 2016 Mar 14;22(10):2922-30. doi: 10.3748/wjg.v22.i10.2922. Review.

10.

Ethical considerations surrounding survival benefit-based liver allocation.

Keller EJ, Kwo PY, Helft PR.

Liver Transpl. 2014 Feb;20(2):140-6. doi: 10.1002/lt.23780. Epub 2013 Dec 12. Review.

11.

A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process.

Shechter SM, Bryce CL, Alagoz O, Kreke JE, Stahl JE, Schaefer AJ, Angus DC, Roberts MS.

Med Decis Making. 2005 Mar-Apr;25(2):199-209.

PMID:
15800304
12.

Ethical Dilemmas in Liver Transplant Organ Allocation: Is it Time for a New Mathematical Model?

Ahearn A.

AMA J Ethics. 2016 Feb 1;18(2):126-32. doi: 10.1001/journalofethics.2016.18.2.nlit1-1602. No abstract available.

13.

Predicting patient survival after liver transplantation using evolutionary multi-objective artificial neural networks.

Cruz-Ramírez M, Hervás-Martínez C, Fernández JC, Briceño J, de la Mata M.

Artif Intell Med. 2013 May;58(1):37-49. doi: 10.1016/j.artmed.2013.02.004. Epub 2013 Mar 13.

PMID:
23489761
14.

Liver and intestine transplantation.

Brown RS, Rush SH, Rosen HR, Langnas AN, Klintmalm GB, Hanto DW, Punch JD.

Am J Transplant. 2004;4 Suppl 9:81-92. Review.

15.

Variation in organ quality between liver transplant centers.

Volk ML, Reichert HA, Lok AS, Hayward RA.

Am J Transplant. 2011 May;11(5):958-64. doi: 10.1111/j.1600-6143.2011.03487.x. Epub 2011 Apr 5.

16.

Patient selection criteria for liver transplantation.

Yu AS, Keeffe EB.

Minerva Chir. 2003 Oct;58(5):635-48. Review.

PMID:
14603144
17.

Evolution in allocation rules for renal, hepatic, pancreatic and intestinal grafts.

Desschans B, Van Gelder F, Van Hees D, de Rocy J, Monbaliu D, Aerts R, Coosemans W, Pirenne J.

Acta Chir Belg. 2008 Jan-Feb;108(1):31-4.

PMID:
18411569
18.

Liver sharing and organ procurement organization performance under redistricted allocation.

Gentry SE, Chow EK, Massie A, Luo X, Shteyn E, Pyke J, Zaun D, Snyder JJ, Israni AK, Kasiske B, Segev DL.

Liver Transpl. 2015 Aug;21(8):1031-9. doi: 10.1002/lt.24171.

19.

Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.

Salvalaggio PR, Afonso RC, Pereira LA, Ferraz-Neto BH.

Transplant Proc. 2012 Oct;44(8):2283-5. doi: 10.1016/j.transproceed.2012.07.045.

PMID:
23026574
20.

Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation.

Volk ML, Lok AS, Pelletier SJ, Ubel PA, Hayward RA.

Gastroenterology. 2008 Nov;135(5):1568-74.

PMID:
19009713

Supplemental Content

Support Center